StockGuru Morning Alerts for Friday, November 3, 2006 Featuring The Immune Response Corporation, EnXnet, Rotoblock, Northamerican Energy, ALR Technologies, and GeneThera

The Immune Response Corporation (OTCBB: IMNR) The Immune Response Corporation (OTCBB: IMNR) – Thursday’s shares went up 3.14% to $0.0197. 3,939,805 shares were traded. The Immune Response Corporation announced on Otober 30th that Dr. Joseph O’Neill, President and CEO, will present an overview of the Company’s immune-based therapies, currently in Phase II clinical trials, at the Rodman & Renshaw Eighth Annual Healthcare Conference in New York City. Dr. O’Neill will discuss a key strategic agreement, signed October 10, 2006, with Accelsiors CRO & Consultancy Services, a clinical research organization (CRO) with extensive experience in conducting multiple sclerosis (MS) trials, to oversee a 200-patient Phase IIb trial of NeuroVax(TM), an investigational T-cell receptor (TCR) peptide vaccine for the treatment of multiple sclerosis (MS). He will review in detail the Company’s drug development pipeline, and status of the Phase II clinical trials in progress for NeuroVax, and for IR103, for the treatment of human immunodeficiency virus (HIV). IR103 is based on the Company’s patented whole-inactivated virus technology, co-invented by Dr. Jonas Salk. The Immune Response Corporation is an immuno-pharmaceutical company focused on developing products to treat autoimmune and infectious diseases. The Company’s lead immune-based therapeutic product candidates are NeuroVax™ for the treatment of MS and IR103 for the treatment of HIV infection. Both of these therapies are in Phase II clinical development and are designed to stimulate pathogen-specific immune responses aimed at slowing or halting the rate of disease progression. EnXnet Inc. (OTCBB: EXNT) EnXnet Inc. (OTCBB: EXNT) – Thursday’s shares closed down 0.72% to $1.38. The volume was 18,940. EnXnet, Inc. announced on November 2nd that they increased their ownership from a 25% to a 35% equity position in Medical D-Tect-OR, LLC by assigning their patent rights for a system to detect foreign objects inside the human body during operations. BAHF, LLC retains 65% equity interest in the joint venture company – Medical D-Tect-OR, LLC. EnXnet’s solution may revolutionize operating room procedures around the world, potentially saving thousands of lives and avoiding otherwise unnecessary additional medical procedures. A working version of this technology has already been displayed and proven. However, Medical-D-Tect-OR, LLC will be demonstrating a more user-friendly working prototype to the medical industry in the near future. “The joint venture with the BAHF is really exciting,” said Ryan Corley, CEO of EnXnet. “They bring a wealth of marketing and distribution expertise to Medical D-Tect-OR.” EnXnet, Inc. is a company that spent its early years finding and developing new technologies with great potential for making valuable impacts in the multimedia environment. EnXnet’s unique products offer their clientele new methods to deter theft, improve listening and viewing experiences, and present information in exciting interactive formats. These technologies and related products, while at the leading edge in their respective applications, are affordable and provide needed solutions to multiple problems. Founded by Ryan Corley in 1999 and based based in Tulsa, Oklahoma as Southern Wireless, Inc., the company changed its name to eMajix.com, Inc. in 2000 and further changed to EnXnet, Inc. in 2001. EnXnet’s mission is to provide their customers with efficient and economic solutions to meet their needs. These solutions range from EnXnet’s OneDisc™/DVDPlus©, which provides DVD and CD formats on opposite sides of one disc for the convenience of the listener/viewer; to their DSTag™ which provides theft deterrents molded into optical disc products and their RFID Deactivation Device which solves personal privacy issues with RFID tracking and theft deterrent tags; to EnXmedia® which provides their clients a one-stop source for their electronic media needs; and ClearVideo® compression which drastically increases the media storage capability of CDs. Rotoblock (OTCBB: ROTB) Rotoblock Corporation (OTCBB: ROTB) – Thursday’s shares decreased 10.00% to $0.09. 62,900 was the volume. Rotoblock announced on October 25th that it won an extension to own and market the Oscillating Piston Engine; a unique and highly advanced internal engine that will give automobiles, airplanes, boats and many other mobile and stationery applications much more power. Rotoblock has spent the last several months negotiating terms to the patent rights and has now signed a 37 month extension agreement which gives Rotoblock extended exclusive rights on the powerful technology. According to Rotoblock President, Matthias Heinze, “We are thrilled for what it means to the health of our company. Now that we are no longer on hold waiting for this extention, we will immediately exploit new markets such as China and India where we know our technology is in high demand. Every indication shows that the Oscillating Piston Engine should surpass performance of current combustion engines on several levels. It is expected to become very popular in the automotive, aviation and marine markets.” Rotoblock Corporation, through its wholly owned subsidiary, Rotoblock Inc., is an engineering/research company dedicated to the development of Oscillating Piston Engine. Rotoblock is focused on the continued development and improvement of the Oscillating Piston Engine to the state where its mechanical, ecological and economic viability leads to the profitable licensing of the manufacturer’s rights to a proprietary patented design or a partnership for its manufacture. The Company was incorporated in Nevada, and is headquartered in Santa Rosa, California. The Company has full rights to the patents of the original Oscillating Piston Engine and believes the Rotoblock Oscillating Piston Engine has particular and useful applications in developing countries such as China and India and will be including these areas in the marketing and commercialization phase of this engine. Northamerican Energy Group Corp. (OTC: NNYG) Northamerican Energy Group Corp. (OTC: NNYG) – Thursday’s shares stayed even at $0.016. 189,100 shares were traded. Northamerican Energy Group Corporation announced on October 24th that it executed an exclusive option with Penergy, of Midland, Texas, to purchase the leases on 1,920 acres encompassing the South Leonard (Queen/Penrose) and Rhodes (Yates/Seven Rivers) Fields in Lea County, New Mexico. These leases have 30 existing wells originally drilled by Tenneco into shallow (under 3000′) reservoirs, with just one of the existing wells currently operating out of the Yates formation; however many of the remaining 29 wells that were temporarily shut in can easily be reworked, at nominal cost, to bring them back on line with anticipated production of 5-10 Blpd of oil, and 50-100 Mcfd of natural gas. The 3-D Seismic, and geological surveys, of both these leases, and in adjacent leases east, and northeast of these leases show good promise and potential in the Devonian (9200′) and EllenBurger (11,700′) zones, as verified by initial natural gas potential of 1555 Mcfpd, 1668 Mcfpd and 4249 Mcfpd in the offsetting wells, as shown in the production reports of the east coast petroleum producer that drilled them. Northamerican Energy Group Corp. specializes in acquiring Oil and Gas leases with proven reserves that have the potential for increased oil and natural gas production utilizing the new well production stimulation systems currently available. Northamerican’s main objective is to locate and acquire Oil and Gas Leases with upside potential for enhanced recovery and to accomplish this by employing: new and vastly improved chemical treatments for treating existing wells, acquisitions where the full potential of the lease has never been properly exploited, well workovers that utilize new equipment and technology, developmental drilling programs to drill new wells into existing proven reserves, and chemical fracture stimulation systems to improve production. ALR Technologies, Inc. (OTCBB: ALRT) ALR Technologies, Inc. (OTCBB: ALRT) – Thursday’s shares increased 20.00% to $0.12. The volume was 5,500. ALR Technologies announced on October 30th that Apple Patch Community, an assisted living organization that is utilizing the ALRT500 system, received a special invitation to present at the prestigious 2006 Institute For Behavioral Health Informatics conference about their innovative, leading edge method for assisted living care for those with mental retardation. Apple Patch executive director, Chris Stevenson, reports that their use of the ALRT500 compliance reminder and monitoring system has generated attention at the national level and that the Apple Patch Community care approach and the ALRT500 monitoring system will be presented in detail at this national meeting on November 9th and 10th in Arlington, VA. “Several officials and companies have heard about the ALRT system since we began use a few months ago and called me about it,” reports Stevenson. “The ALRT compliance system has provided our caregivers with the assistance needed to remember to complete or administer the many activities and medications that are essential for quality care. The ability to remind and to monitor at such an affordable price is remarkable. We expected the cost to be substantially higher. Our monitoring has allowed for education changes and timing changes to help improve behavior. Not only are we providing more accurate and timely care but it also makes us more cost efficient.” ALR Technologies, Inc. is a pioneer in the emerging market for home health management and disease management industry. ALRT has developed technology-based, “clinically proven” medication reminder products and compliance monitoring and health intervention systems servicing the health care industry. ALRT’s products have been developed to address the growing problem of patient adherence to medical disease management treatments and activities that contribute to more than $140 billion dollars annually in excess healthcare costs. Healthcare costs in the US account for 15% of the gross domestic product and is expected to reach 25% by 2020. ALRT’s flagship product, the ALRT500 Health Management system, provides continued ongoing assistance to the patient and continued oversight after the patient has been released from the hospital, medical clinic, or the case manager has left their home. GeneThera Inc. (OTCBB: GTHA) GeneThera Inc. (OTCBB: GTHA) – Thursday’s shares closed down 6.67% to $0.042. 224,033 was the volume. GeneThera announced on November 1st that it will be the main subject of a Media Campaign being led by InvestInItaly. InvestInItaly has designed a press program that will feature GeneThera and its collaboration with IZSLER as previously announced. The campaign will feature GeneThera and a quote from Dr. Tony Milici, CEO, and be published in various magazines and journals such as Les Echos, Le Monde, Le Figaro, La Tribune, Handelsblatt, L’Express, Investir, Le Pointe, L’usine Nouvelle, Nature, Science, Scrip WP Newsletter, Chemistry Today and New Scientist. Many of these publications have worldwide publication. GeneThera, Inc., a development stage company, develops molecular assays for the detection of food contaminating pathogens, veterinary diseases, and genetically modified organisms primarily in the United States. In addition, it is in process of developing therapeutic vaccines for the detection of chronic wasting disease, a disease affecting elk and deer in North America; and mad cow disease. GeneThera has an agreement with Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna to collaborate on scientific research related to the diagnosis of animal transmittable diseases, such as Mad Cow Disease and Scrapie. The company, formerly known as Hand Brand Distribution, Inc., was founded by Antonio Milici. GeneThera was incorporated in 1995 and is based in Wheat Ridge, Colorado. We Invite you to Visit the All New StockGuru Blog! Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks. Click HERE to visit the Blog, or go to: http://stockguru.com/blog/ StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 453-4268. Web: StockGuru.com. Email: Publisher@stockguru.com. IMNR Disclosure: Pentony Enterprises LLC was compensated $50,000 from ROI Group Associates Inc. for profile coverage. EXNT Disclosure: Pentony Enterprises LLC was compensated $11,000 from a non-controlling third party for profile coverage. ROTB Disclosure: Pentony Enterprises LLC was compensated 250,000 free trading shares from a non-controlling third party for profile coverage. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. NNYG Disclosure: Pentony Enterprises LLC was compensated 2,700,000 free trading shares from a non-controlling third party for profile coverage. ALRT Disclosure: Pentony Enterprises LLC was compensated $15,000 from a non-controlling third party for profile coverage. GTHA Disclosure: Pentony Enterprises LLC was compensated 500,000 free trading shares from a non-controlling third party for profile coverage. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. We currently hold 233,000 shares. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.